Stock Yearly Return 2015
Start date: 12/31/2014
End date: 12/31/2015
Start price/share: $55.05
End price/share: $81.90
Dividends collected/share: $0.00
Total return: 48.77%
Average Annual Total Return: 48.77%
Starting investment: $10,000.00
Ending investment: $14,877.00
Years: 1.00


DXCM average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare DXCM average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into DXCM


Also see:
DXCM stock yearly return 2016
DXCM stock yearly return 2017
DXCM stock yearly return 2018
DXCM stock yearly return 2019
DXCM stock yearly return 2020
DXCM YTD return
DXCM average annual return 10 years
DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring systems for use by people with diabetes and by healthcare providers. Co.'s products include: DecCom G6®, which allows Co.'s transmitter to run an algorithm to generate a glucose value and to communicate to a patient's mobile device; DexCom G4® PLATINUM, which is used to adjust therapy and to educate and motivate patients to modify their behavior after viewing the effects that specific foods, exercise, stress and medications have on their glucose levels; and DexCom Share®, which transmits glucose information to the mobile devices of designated recipients. The DXCM stock yearly return is shown above.

The yearly return on the DXCM stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2015 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the DXCM annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for DXCM:
DXCM SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
DexCom (DXCM) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

DYNT Average Annual Return
EBS Average Annual Return
ECYT Average Annual Return
EDAP Average Annual Return
EDGE Average Annual Return
EDIT Average Annual Return
EGLT Average Annual Return
EGRX Average Annual Return
EHC Average Annual Return
EIGR Average Annual Return
More Healthcare companies »

 

DXCM Stock Yearly Return 2015 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.